Yahui Zhu

PD-1 blockade plus chemoradiotherapy as preoperative therapy for patients with BRPC/LAPC: A biomolecular exploratory, phase II trial

Juan Du, Changchang Lu, Liang Mao et al. · Cell Reports Medicine · 2023 · 37 citations · Full text

Medicine, Oncology, Chemotherapy +16

First-line penpulimab (an anti-PD1 antibody) and anlotinib (an angiogenesis inhibitor) with nab-paclitaxel/gemcitabine (PAAG) in metastatic pancreatic cancer: a prospective, multicentre, biomolecular exploratory, phase II trial

Huizi Sha, Fan Tong, Jiayao Ni et al. · Signal Transduction and Targeted Therapy · 2024 · 34 citations · Full text

Medicine, Oncology, Pharmacology +16

Biomarkers for predicting tumor response to PD-1 inhibitors in patients with advanced pancreatic cancer

Xin Qiu, Zhan Shi, Fan Tong et al. · Human Vaccines & Immunotherapeutics · 2023 · 29 citations · Full text

Medicine, Oncology, Pharmacology +17

CT radiomics-based biomarkers can predict response to immunotherapy in hepatocellular carcinoma

Liang Qi, Yahui Zhu, Jinxin Li et al. · Scientific Reports · 2024 · 23 citations · Full text

Medicine, Oncology, Radiology +17

High DSCC1 Level Predicts Poor Prognosis of Lung Adenocarcinoma

Sisi Chang, Yahui Zhu, Yutan Xi et al. · International Journal of General Medicine · 2021 · 18 citations · Full text

Medicine, Oncology, Pathology +17